Heron Therapeutics Inc (HRTX)
2.985
+0.18
(+6.23%)
USD |
NASDAQ |
May 15, 15:20
Heron Therapeutics Accounts Payable (Quarterly): 0.837M for March 31, 2024
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 0.837M |
December 31, 2023 | 3.799M |
September 30, 2023 | 1.86M |
June 30, 2023 | 1.957M |
March 31, 2023 | 4.065M |
December 31, 2022 | 3.588M |
September 30, 2022 | 6.547M |
June 30, 2022 | 13.80M |
March 31, 2022 | 8.226M |
December 31, 2021 | 3.873M |
September 30, 2021 | 5.885M |
June 30, 2021 | 11.24M |
March 31, 2021 | 1.689M |
December 31, 2020 | 0.629M |
September 30, 2020 | 12.07M |
June 30, 2020 | 18.46M |
March 31, 2020 | 11.56M |
December 31, 2019 | 3.068M |
September 30, 2019 | 1.627M |
June 30, 2019 | 7.997M |
March 31, 2019 | 10.81M |
December 31, 2018 | 17.09M |
September 30, 2018 | 9.644M |
June 30, 2018 | 4.979M |
March 31, 2018 | 11.46M |
Date | Value |
---|---|
December 31, 2017 | 18.92M |
September 30, 2017 | 5.337M |
June 30, 2017 | 6.315M |
March 31, 2017 | 4.477M |
December 31, 2016 | 7.853M |
September 30, 2016 | 6.09M |
June 30, 2016 | 8.661M |
March 31, 2016 | 6.861M |
December 31, 2015 | 3.336M |
September 30, 2015 | 2.735M |
June 30, 2015 | 2.987M |
March 31, 2015 | 2.383M |
December 31, 2014 | 3.435M |
September 30, 2014 | 1.475M |
June 30, 2014 | 1.769M |
March 31, 2014 | 3.603M |
December 31, 2013 | 1.29M |
September 30, 2013 | 2.25M |
June 30, 2013 | 5.35M |
March 31, 2013 | 3.825M |
December 31, 2012 | 1.912M |
September 30, 2012 | 1.758M |
June 30, 2012 | 0.605M |
March 31, 2012 | 0.89M |
December 31, 2011 | 1.01M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
0.629M
Minimum
Dec 2020
18.46M
Maximum
Jun 2020
6.139M
Average
3.969M
Median
Accounts Payable (Quarterly) Benchmarks
United Therapeutics Corp | -- |
Esperion Therapeutics Inc | 28.43M |
Aldeyra Therapeutics Inc | 0.2803M |
Ocular Therapeutix Inc | 6.453M |
Alpine Immune Sciences Inc | 4.17M |